Literature DB >> 25238585

Effect of retinal ischemia on the non-image forming visual system.

María Florencia González Fleitas1, Melina Bordone, Ruth E Rosenstein, Damián Dorfman.   

Abstract

Retinal ischemic injury is an important cause of visual impairment. The loss of retinal ganglion cells (RGCs) is a key sign of retinal ischemic damage. A subset of RGCs expressing the photopigment melanopsin (mRGCs) regulates non-image-forming visual functions such as the pupillary light reflex (PLR), and circadian rhythms. We studied the effect of retinal ischemia on mRGCs and the non-image-forming visual system function. For this purpose, transient ischemia was induced by raising intraocular pressure to 120 mm Hg for 40 min followed by retinal reperfusion by restoring normal pressure. At 4 weeks post-treatment, animals were subjected to electroretinography and histological analysis. Ischemia induced a significant retinal dysfunction and histological alterations. At this time point, a significant decrease in the number of Brn3a(+) RGCs and in the anterograde transport from the retina to the superior colliculus and lateral geniculate nucleus was observed, whereas no differences in the number of mRGCs, melanopsin levels, and retinal projections to the suprachiasmatic nuclei and the olivary pretectal nucleus were detected. At low light intensity, a decrease in pupil constriction was observed in intact eyes contralateral to ischemic eyes, whereas at high light intensity, retinal ischemia did not affect the consensual PLR. Animals with ischemia in both eyes showed a conserved locomotor activity rhythm and a photoentrainment rate which did not differ from control animals. These results suggest that the non-image forming visual system was protected against retinal ischemic damage.

Entities:  

Keywords:  Ischemia; melanopsin; non-image forming visual system; retina

Mesh:

Substances:

Year:  2014        PMID: 25238585     DOI: 10.3109/07420528.2014.959526

Source DB:  PubMed          Journal:  Chronobiol Int        ISSN: 0742-0528            Impact factor:   2.877


  7 in total

1.  Melatonin Prevents Non-image-Forming Visual System Alterations Induced by Experimental Glaucoma in Rats.

Authors:  María F González Fleitas; Julián Devouassoux; Marcos L Aranda; Hernán H Dieguez; Juan S Calanni; Agustina Iaquinandi; Pablo H Sande; Damián Dorfman; Ruth E Rosenstein
Journal:  Mol Neurobiol       Date:  2021-03-31       Impact factor: 5.590

2.  Enriched Environment Protects the Optic Nerve from Early Diabetes-Induced Damage in Adult Rats.

Authors:  Damián Dorfman; Marcos L Aranda; Ruth E Rosenstein
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

3.  Dissociation of Pupillary Post-Illumination Responses from Visual Function in Confirmed OPA1 c.983A > G and c.2708_2711delTTAG Autosomal Dominant Optic Atrophy.

Authors:  Claus Nissen; Cecilia Rönnbäck; Birgit Sander; Kristina Herbst; Dan Milea; Michael Larsen; Henrik Lund-Andersen
Journal:  Front Neurol       Date:  2015-02-04       Impact factor: 4.003

Review 4.  Shared and Differential Retinal Responses against Optic Nerve Injury and Ocular Hypertension.

Authors:  Manuel Vidal-Sanz; Caridad Galindo-Romero; Francisco J Valiente-Soriano; Francisco M Nadal-Nicolás; Arturo Ortin-Martinez; Giuseppe Rovere; Manuel Salinas-Navarro; Fernando Lucas-Ruiz; Maria C Sanchez-Migallon; Paloma Sobrado-Calvo; Marcelino Aviles-Trigueros; María P Villegas-Pérez; Marta Agudo-Barriuso
Journal:  Front Neurosci       Date:  2017-04-26       Impact factor: 4.677

5.  Low-dose minocycline mediated neuroprotection on retinal ischemia-reperfusion injury of mice.

Authors:  Ruojing Huang; Shaomin Liang; Lyujie Fang; Min Wu; Huanhuan Cheng; Xuesong Mi; Yong Ding
Journal:  Mol Vis       Date:  2018-05-18       Impact factor: 2.367

6.  Subtype-specific response of retinal ganglion cells to optic nerve crush.

Authors:  S Daniel; A F Clark; C M McDowell
Journal:  Cell Death Discov       Date:  2018-06-28

Review 7.  Melanopsin retinal ganglion cell loss and circadian dysfunction in Alzheimer's disease (Review).

Authors:  Ruiqi Feng; Lijuan Li; Haiyan Yu; Min Liu; Wei Zhao
Journal:  Mol Med Rep       Date:  2016-03-02       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.